Higher excess mortality found in Massachusetts during Omicron period than the Delta period

NewsGuard 100/100 Score

The COVID-19 pandemic has led to excess deaths -; a higher number of fatalities than would be expected over a given period. A new study compares excess deaths during the pandemic period when the Delta variant dominated (June 28, 2021-December 5, 2021), during the transition from Delta to the Omicron variant (December 6-26, 2021) and when Omicron dominated (December 27, 2021-February 20, 2022) in Massachusetts. Investigators found that excess deaths were higher during the 8-week Omicron period compared to the 23-week Delta period (2,294 deaths versus 1,975).

In terms of excess death, we found that Omicron was actually much worse for Massachusetts than Delta. Others have reported that the Omicron variant may cause milder COVID-19. Assuming that's the case, what we're seeing here may reflect just how much more infectious Omicron has been. This could mean that highly contagious variants, even if they cause relatively milder illness, can still lead to substantial excess mortality, even in a highly vaccinated population."

Jeremy Faust, MD, Department of Emergency Medicine, Brigham and Women's Hospital

Source:
Journal reference:

Faust, J.S., et al. (2022) Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19. JAMA. doi.org/10.1001/jama.2022.8045.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S